designation

Pulse stock rallies 22% on FDA breakthrough designation (NASDAQ:PLSE)

designer491 Pulse Biosciences (NASDAQ:PLSE) stock rallied 22% in morning trading Monday after the medtech company said it had received FDA breakthrough device designation for its CellFX nanosecond pulse field ablation cardiac surgery system for the treatment of atrial fibrillation, or AFib. Pulse said it plans to pursue a premarket approvalContinue Reading

Humacyte stock rallies 19% on FDA RMAT designation (NASDAQ:HUMA)

In: Finance

JHVEPhoto Humacyte (NASDAQ:HUMA) stock rallied 19% Monday on news that the company has received FDA regenerative medicine advanced therapy, or RMAT, designation for its product candidate Acellular Tissue Engineered Vessel, or ATEV, for the treatment of peripheral artery disease. The biotech company noted it was the third RMAT designation forContinue Reading

designation

Pulse stock rallies 22% on FDA breakthrough designation (NASDAQ:PLSE)

Humacyte stock rallies 19% on FDA RMAT designation (NASDAQ:HUMA)

Build a FinOps agent using Amazon Bedrock with multi-agent capability and Amazon Nova as the foundation model | Amazon Web Services

Stream ingest data from Kafka to Amazon Bedrock Knowledge Bases using custom connectors | Amazon Web Services